ng-nitroarginine methyl ester has been researched along with Angiospasm, Intracranial in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Andereggen, L; Kashefiolasl, S; Konczalla, J; Marbacher, S; Mrosek, J; Wanderer, S | 1 |
Göksel, HM; Karadag, O; Oztoprak, I; Taş, F; Turaçlar, U | 1 |
2 other study(ies) available for ng-nitroarginine methyl ester and Angiospasm, Intracranial
Article | Year |
---|---|
The Role of Losartan as a Potential Neuroregenerative Pharmacological Agent after Aneurysmal Subarachnoid Haemorrhage.
Topics: Animals; Basilar Artery; Disease Models, Animal; Endothelin-1; Losartan; Male; NG-Nitroarginine Methyl Ester; Rats; Rats, Sprague-Dawley; Receptor, Endothelin B; Regenerative Medicine; Subarachnoid Hemorrhage; Vasoconstriction; Vasodilation; Vasodilator Agents; Vasospasm, Intracranial | 2020 |
Nitric oxide synthase inhibition attenuates vasoactive response to spinal cord stimulation in an experimental cerebral vasospasm model.
Topics: Animals; Blood Flow Velocity; Carotid Artery, Internal; Cerebrovascular Circulation; Disease Models, Animal; Electric Stimulation Therapy; Female; Male; NG-Nitroarginine Methyl Ester; Oximetry; Rabbits; Spinal Cord; Subarachnoid Hemorrhage; Ultrasonography, Doppler, Transcranial; Vasodilation; Vasospasm, Intracranial | 2001 |